Patents Assigned to Galephar P.R., Inc., Ltd.
  • Extended release form of diltiazem
    Patent number: 5529791
    Abstract: An extended-release galenical form of Diltiazem or a pharmaceutically acceptable salt thereof, which comprises beads containing said Diltiazem or a pharmaceutically acceptable salt thereof as an active ingredient and a wetting agent, said beads being coated with a microporous membrane comprising at least a water-soluble or water-dispersible polymer or copolymer and a pharmaceutically acceptable adjuvant.
    Type: Grant
    Filed: September 23, 1994
    Date of Patent: June 25, 1996
    Assignee: Galephar P.R., Inc., Ltd.
    Inventors: Arthur M. Deboeck, Philippe R. Baudier
  • Extended release form of diltiazem
    Patent number: 5288505
    Abstract: An extended-release galenical form of Diltiazem or a pharmaceutically acceptable salt thereof, which comprises beads containing said Diltiazem or a pharmaceutically acceptable salt thereof as an active ingredient and a wetting agent, said beads being coated with a microporous membrane comprising at least a water-soluble or water-dispersible polymer or copolymer and a pharmaceutically acceptable adjuvant.
    Type: Grant
    Filed: June 26, 1991
    Date of Patent: February 22, 1994
    Assignee: Galephar P.R., Inc., Ltd.
    Inventors: Arthur M. Deboeck, Philippe R. Baudier